Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by BiondVax Pharmaceuticals Ltd.
BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics
September 06, 2023
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
BiondVax Reports Second Quarter Financial Results and Provides Business Update
August 11, 2023
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
Nasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules
August 01, 2023
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
BiondVax signs exclusive license agreement for development and commercialization of a novel anti-IL-17 antibody for treatment of autoimmune and inflammatory diseases including psoriasis
June 05, 2023
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
BiondVax Files FY 2022 Financial Statements and Annual Report on Form 10-K and Provides Business Update
April 17, 2023
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
BiondVax to Present at BIO-Europe Spring
March 16, 2023
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
BiondVax Presenting at BIO CEO & Investor Conference
February 02, 2023
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
BiondVax’s Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo Study
January 23, 2023
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
BiondVax’s Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study
January 06, 2023
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
BiondVax to Present at Biotech Showcase 2023
January 05, 2023
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
BiondVax CEO Issues Letter to Shareholders
December 30, 2022
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
BiondVax Announces Closing of $8 Million Underwritten Public Offering
December 20, 2022
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
BiondVax Announces Pricing of $8 Million Underwritten Public Offering
December 16, 2022
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
Professor Dr. Matthias Dobbelstein joins BiondVax’s Scientific Advisory Board
December 06, 2022
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
BiondVax announces Third Quarter 2022 Financial Results and Provides Business Update
November 30, 2022
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
BiondVax reports successful results in preclinical in vivo study of its innovative inhaled COVID-19 NanoAb therapy
November 29, 2022
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
BiondVax Congratulates Dirk Görlich on $1.4 million WLA Prize in Life Sciences
November 15, 2022
From
BiondVax Pharmaceuticals Ltd.
Via
GlobeNewswire
Tickers
BVXV
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit